Moreover, although tau ubiquitination and acetylation on lysine residues is characteristic of late-stage AD, these modifications were largely absent from both FTD/P301L patients and mouse models (with the exception of tau ubiquitination in the first microtubule-binding repeat domain detected in rTg4510 mice with aging). This evidence concerns the gene MAPT and Alzheimer disease.